Arch Therapeutics, Inc.

OTCPK:ARTH Stock Report

Market Cap: US$888.9k

Arch Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ARTH?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,2870.029%
Individual Insiders145,9193.28%
Institutions450,00010.1%
General Public3,847,15886.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 16 shareholders own 13.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.75%
Oasis Capital, LLC
300,000US$60.0k0%100.0%
0.84%
Walleye Capital LLC
37,500US$7.5k0%no data
0.84%
Cavalry Fund I Management, LLC
37,500US$7.5k0%3.03%
0.84%
Sixth Borough Capital Management, LP.
37,500US$7.5k0%0.19%
0.84%
Andrew Stahl
37,500US$7.5k0%no data
0.66%
Ana Parker
29,430US$5.9k0%no data
0.42%
District 2 Capital LP
18,750US$3.8k0%0.06%
0.42%
Brandt Wilson
18,750US$3.8k0%no data
0.42%
Bigger Capital, LLC
18,750US$3.8k0%0.03%
0.42%
Mona Wilson
18,750US$3.8k0%no data
0.34%
Terrence Norchi
15,005US$3.0k0%no data
0.22%
Michael Abrams
9,795US$2.0k0%no data
0.19%
Laurence Hicks
8,525US$1.7k0%no data
0.18%
Michael Parker
8,070US$1.6k0%no data
0.029%
Drake Partners Equity Llc
1,287US$257.40%no data
0.0021%
Daniel Yrigoyen
94US$18.80%no data